Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat

Mitchel Tate, Minh Deo, Anh H Cao, Sally G Hood, Karina Huynh, Helen Kiriazis, Xiao-Jun Du, Tracey L Julius, Gemma A Figtree, Gregory J Dusting, David M Kaye, Rebecca H Ritchie

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Diabetic cardiomyopathy is a major contributor to the increasing burden of heart failure globally. Effective therapies remain elusive, in part due to the incomplete understanding of the mechanisms underlying diabetes-induced myocardial injury. The objective of this study was to assess the direct impact of insulin replacement on left ventricle structure and function in a rat model of diabetes. Male Sprague-Dawley rats were administered streptozotocin (55 mg/kg i.v.) or citrate vehicle and were followed for 8 weeks. A subset of diabetic rats were allocated to insulin replacement (6 IU/day insulin s.c.) for the final 4 weeks of the 8-week time period. Diabetes induced the characteristic systemic complications of diabetes (hyperglycaemia, polyuria, kidney hypertrophy) and was accompanied by marked left ventricle remodelling (cardiomyocyte hypertrophy, left ventricle collagen content) and diastolic dysfunction (transmitral E/A, left ventricle-dP/dt). Importantly, these systemic and cardiac impairments were ameliorated markedly following insulin replacement, and moreover, markers of the diabetic cardiomyopathy phenotype were significantly correlated with the extent of hyperglycaemia. In summary, these data suggest that poor glucose control directly contributes towards the underlying features of experimental diabetic cardiomyopathy, at least in the early stages, and that adequate replacement ameliorates this.
Original languageEnglish
Pages (from-to)423-433
Number of pages11
JournalDiabetes and Vascular Disease Research
Volume14
Issue number5
DOIs
Publication statusPublished - 2017

Keywords

  • Diabetes
  • diabetic cardiomyopathy
  • insulin
  • diastolic dysfunction
  • cardiac remodelling
  • myocardial inflammation

Cite this

Tate, Mitchel ; Deo, Minh ; Cao, Anh H ; Hood, Sally G ; Huynh, Karina ; Kiriazis, Helen ; Du, Xiao-Jun ; Julius, Tracey L ; Figtree, Gemma A ; Dusting, Gregory J ; Kaye, David M ; Ritchie, Rebecca H. / Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat. In: Diabetes and Vascular Disease Research. 2017 ; Vol. 14, No. 5. pp. 423-433.
@article{4f2d08fd2d5d4b888bed48d1d559103b,
title = "Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat",
abstract = "Diabetic cardiomyopathy is a major contributor to the increasing burden of heart failure globally. Effective therapies remain elusive, in part due to the incomplete understanding of the mechanisms underlying diabetes-induced myocardial injury. The objective of this study was to assess the direct impact of insulin replacement on left ventricle structure and function in a rat model of diabetes. Male Sprague-Dawley rats were administered streptozotocin (55 mg/kg i.v.) or citrate vehicle and were followed for 8 weeks. A subset of diabetic rats were allocated to insulin replacement (6 IU/day insulin s.c.) for the final 4 weeks of the 8-week time period. Diabetes induced the characteristic systemic complications of diabetes (hyperglycaemia, polyuria, kidney hypertrophy) and was accompanied by marked left ventricle remodelling (cardiomyocyte hypertrophy, left ventricle collagen content) and diastolic dysfunction (transmitral E/A, left ventricle-dP/dt). Importantly, these systemic and cardiac impairments were ameliorated markedly following insulin replacement, and moreover, markers of the diabetic cardiomyopathy phenotype were significantly correlated with the extent of hyperglycaemia. In summary, these data suggest that poor glucose control directly contributes towards the underlying features of experimental diabetic cardiomyopathy, at least in the early stages, and that adequate replacement ameliorates this.",
keywords = "Diabetes, diabetic cardiomyopathy, insulin, diastolic dysfunction, cardiac remodelling, myocardial inflammation",
author = "Mitchel Tate and Minh Deo and Cao, {Anh H} and Hood, {Sally G} and Karina Huynh and Helen Kiriazis and Xiao-Jun Du and Julius, {Tracey L} and Figtree, {Gemma A} and Dusting, {Gregory J} and Kaye, {David M} and Ritchie, {Rebecca H}",
year = "2017",
doi = "10.1177/1479164117710390",
language = "English",
volume = "14",
pages = "423--433",
journal = "Diabetes and Vascular Disease Research",
issn = "1479-1641",
publisher = "SAGE Publications Ltd",
number = "5",

}

Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat. / Tate, Mitchel; Deo, Minh; Cao, Anh H; Hood, Sally G; Huynh, Karina; Kiriazis, Helen; Du, Xiao-Jun; Julius, Tracey L; Figtree, Gemma A; Dusting, Gregory J; Kaye, David M; Ritchie, Rebecca H.

In: Diabetes and Vascular Disease Research, Vol. 14, No. 5, 2017, p. 423-433.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat

AU - Tate, Mitchel

AU - Deo, Minh

AU - Cao, Anh H

AU - Hood, Sally G

AU - Huynh, Karina

AU - Kiriazis, Helen

AU - Du, Xiao-Jun

AU - Julius, Tracey L

AU - Figtree, Gemma A

AU - Dusting, Gregory J

AU - Kaye, David M

AU - Ritchie, Rebecca H

PY - 2017

Y1 - 2017

N2 - Diabetic cardiomyopathy is a major contributor to the increasing burden of heart failure globally. Effective therapies remain elusive, in part due to the incomplete understanding of the mechanisms underlying diabetes-induced myocardial injury. The objective of this study was to assess the direct impact of insulin replacement on left ventricle structure and function in a rat model of diabetes. Male Sprague-Dawley rats were administered streptozotocin (55 mg/kg i.v.) or citrate vehicle and were followed for 8 weeks. A subset of diabetic rats were allocated to insulin replacement (6 IU/day insulin s.c.) for the final 4 weeks of the 8-week time period. Diabetes induced the characteristic systemic complications of diabetes (hyperglycaemia, polyuria, kidney hypertrophy) and was accompanied by marked left ventricle remodelling (cardiomyocyte hypertrophy, left ventricle collagen content) and diastolic dysfunction (transmitral E/A, left ventricle-dP/dt). Importantly, these systemic and cardiac impairments were ameliorated markedly following insulin replacement, and moreover, markers of the diabetic cardiomyopathy phenotype were significantly correlated with the extent of hyperglycaemia. In summary, these data suggest that poor glucose control directly contributes towards the underlying features of experimental diabetic cardiomyopathy, at least in the early stages, and that adequate replacement ameliorates this.

AB - Diabetic cardiomyopathy is a major contributor to the increasing burden of heart failure globally. Effective therapies remain elusive, in part due to the incomplete understanding of the mechanisms underlying diabetes-induced myocardial injury. The objective of this study was to assess the direct impact of insulin replacement on left ventricle structure and function in a rat model of diabetes. Male Sprague-Dawley rats were administered streptozotocin (55 mg/kg i.v.) or citrate vehicle and were followed for 8 weeks. A subset of diabetic rats were allocated to insulin replacement (6 IU/day insulin s.c.) for the final 4 weeks of the 8-week time period. Diabetes induced the characteristic systemic complications of diabetes (hyperglycaemia, polyuria, kidney hypertrophy) and was accompanied by marked left ventricle remodelling (cardiomyocyte hypertrophy, left ventricle collagen content) and diastolic dysfunction (transmitral E/A, left ventricle-dP/dt). Importantly, these systemic and cardiac impairments were ameliorated markedly following insulin replacement, and moreover, markers of the diabetic cardiomyopathy phenotype were significantly correlated with the extent of hyperglycaemia. In summary, these data suggest that poor glucose control directly contributes towards the underlying features of experimental diabetic cardiomyopathy, at least in the early stages, and that adequate replacement ameliorates this.

KW - Diabetes

KW - diabetic cardiomyopathy

KW - insulin

KW - diastolic dysfunction

KW - cardiac remodelling

KW - myocardial inflammation

UR - http://www.scopus.com/inward/record.url?scp=85029691432&partnerID=8YFLogxK

U2 - 10.1177/1479164117710390

DO - 10.1177/1479164117710390

M3 - Article

VL - 14

SP - 423

EP - 433

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

SN - 1479-1641

IS - 5

ER -